Pharmaceutical Injection Manufacturer in India

WHO-GMP certified sterile injectable manufacturing across Small Volume Parenterals — vials, ampoules and dry powder injections — for domestic supply, institutional tenders and international export markets.

Key Highlights

WHO-GMP
Certified Facility
SVP — Vials
Ampoules · Dry Powder
15+ Countries
Supplied
Audit-Ready
Documentation

Request A Product List

Download Capability Brochure

About Injections

Our injectable manufacturing
capability at 9M India

9M India operates a WHO-GMP certified sterile manufacturing facility producing Small Volume Parenterals across three container closure systems — vial liquids, ampoules and dry powder injections.

Our injectable range covers five major therapeutic categories: analgesic and pain-relief, anaesthetic, cardiovascular, gastrointestinal and anti-inflammatory formulations. Every molecule in our portfolio is backed by a valid DCGI manufacturing licence and complete regulatory documentation.

Manufacturing takes place in classified cleanroom environments under validated aseptic processes. Every batch undergoes full in-house analytical testing — sterility, particulate matter, endotoxin levels and potency — before release. No batch leaves without a Certificate of Analysis issued from our own QC laboratory.

For buyers requiring institutional tender supply, export registration or third-party contract manufacturing, our documentation package — COA, COC, stability data and regulatory dossiers — is pre-prepared and available within 24 hours of request.

Sterile cleanroom manufacturing with aseptic fill-finish
Three container systems — vial liquid, ampoules, dry powder injections (SVP)
In-house sterility, endotoxin and potency testing on every batch
DCGI-approved formulations with complete regulatory documentation
Cold chain storage and dispatch capability for temperature-sensitive injectables

Enquire Now

Our Capabilities

Injectable manufacturing capabilities at 9M India

Our sterile injectable facility is built to handle the full complexity of parenteral manufacturing - from formulation development through aseptic fill-finish to regulatory release and cold chain dispatch.

01

Our injectable production takes place in classified cleanroom environments designed for aseptic manufacturing. Fill-finish operations for vial liquids, ampoule sealing and dry powder filling are conducted under validated conditions — with environmental monitoring, personnel gowning protocols and contamination controls maintained as standard. Every process parameter is documented, reviewed and retained for regulatory inspection.
02

9M India manufactures Small Volume Parenterals across all three primary container formats. Vial liquids for multi-dose and single-dose requirements. Ampoules for single-use sterile preparations. Dry powder injections for molecules requiring reconstitution at point of use. Container closure integrity is tested on every batch as part of our standard quality release protocol.
03

Every injectable batch is tested in our in-house analytical laboratory before dispatch. Testing covers sterility, particulate matter (visible and sub-visible), bacterial endotoxins (LAL test), pH, assay and related substances. Certificates of Analysis are issued directly from our QC facility — not from a third-party laboratory — ensuring complete chain-of-custody accountability for every batch released.
04

Our documentation is prepared for the full range of institutional, export and tender requirements. Available on request: Manufacturing Licence, DCGI product approvals, WHO-GMP Certificate, Certificate of Analysis, Certificate of Conformance, stability study data (ICH-aligned), process validation reports and product dossiers for export registration. Technical bid support for government and institutional tender submissions is available as standard.
05

Injectable formulations with specific temperature requirements are stored and dispatched under controlled conditions. Our facility supports ambient (+15°C to +30°C), controlled room temperature (+15°C to +25°C) and refrigerated (+2°C to +8°C) storage. Cold chain logistics are managed from our facility to final delivery point — with temperature records maintained and available for regulatory review.

Therapeutic Categories

Injectable formulations across 5 therapeutic categories

Our injectable portfolio covers the five therapeutic categories most frequently demanded in institutional supply, hospital procurement and international export programmes.

Analgesic (Pain-Relief) Injections
- Non-Opioid Analgesics
- Paracetamol
High-purity non-opioid analgesic injectables — the most widely procured injectable category in government and institutional hospital supply.
Anaesthetic Injections
- Local Anaesthetics
- General Anaesthetics
- Regional Anaesthesia
- Lidocaine
- Propofol
- Ropivacaine
Sterile anaesthetic injectables for surgical, procedural, and regional anaesthesia — manufactured to meet strict purity and stability standards.
Cardiovascular Injections
- Antihypertensive
- Antiarrhythmic
- Anticoagulants
- Labetalol
- Adenosine
- Heparin
Critical care cardiovascular injectables — including antihypertensives, antiarrhythmics, and anticoagulants for ICU and emergency use.
Gastrointestinal (GI) Injections
- Anti-nausea & Anti-emetics
- Corticosteroids for GI
- Proton Pump Inhibitors (PPIs)
- Ondansetron
- Methylprednisolone
- Pantoprazole
GI injectable formulations for hospital and critical care — covering anti-emetics, corticosteroids, and PPIs in multiple formats.
Anti-inflammatory Injections
- Corticosteroids
- NSAIDs
- Dexamethasone
- Ketorolac
Anti-inflammatory injectable solutions including corticosteroids and NSAIDs — commonly used in orthopaedic and post-surgical care.

Why Choose Us

Why choose 9M India for injectable manufacturing

Sterile injectable manufacturing is the most demanding category in pharmaceutical production. It requires classified infrastructure, validated processes, and documentation discipline that most manufacturers cannot sustain at scale. 9M India is built for exactly this.

Sterile manufacturing. No shortcuts.

Classified cleanroom environments, aseptic fill-finish, in-process environmental monitoring, validated sterilisation — the complete sterile manufacturing standard applied to every batch without exception. Not claimed. Validated.
One of fewer than 18% of Indian plants that is globally compliant.

WHO-GMP certification for sterile injectable manufacturing places 9M India in a small, verified category of Indian manufacturers qualified for international institutional supply, government tender participation and export to regulated markets across 15+ countries.
Every document ready before you ask.

COA, COC, sterility test reports, endotoxin data, stability dossiers, DCGI approvals, WHO-GMP certificate — maintained, version-controlled and available for submission within 24 hours. Your tender deadline does not depend on our paperwork.

Our Injections Range

Injectable formulations manufactured at 9M India

Key molecules from our injectable manufacturing portfolio — across all five therapeutic categories, three container formats and the full spectrum of institutional and export supply requirements.

01

Paracetamol

Analgesic · Pain-Relief Container: Vial liquid Type: Non-opioid analgesic
02

Propofol

Anaesthetic Container: Vial liquid Type: General anaesthesia
03

Lidocaine

Anaesthetic Container: Ampoule Type: Local anaesthesia
04

Ropivacaine

Anaesthetic Container: Ampoule Type: Regional anaesthesia
05

Heparin

Cardiovascular Container: Vial liquid Type: Anticoagulant
06

Labetalol

Cardiovascular Container: Ampoule Type: Antihypertensive
07

Adenosine

Cardiovascular Container: Vial liquid Type: Antiarrhythmic
08

Ondansetron

Gastrointestinal Container: Vial liquid Type: Anti-emetic
09

Pantoprazole

Gastrointestinal Container: Dry powder Type: Proton Pump Inhibitor
10

Methylprednisolone

Gastrointestinal Container: Dry powder Type: Corticosteroid
11

Dexamethasone

Anti-inflammatory Container: Ampoule Type: Corticosteroid
12

Ketorolac

Anti-inflammatory Container: Ampoule Type: NSAID

We keep answer short

Frequently asked questions
— injectable manufacturing

01

9M India manufactures Small Volume Parenterals (SVP) across three container closure systems — vial liquids, ampoules and dry powder injections. Our injectable portfolio covers five therapeutic categories: analgesic and pain-relief, anaesthetic, cardiovascular, gastrointestinal and anti-inflammatory formulations. Key molecules include Paracetamol, Propofol, Lidocaine, Heparin, Ondansetron, Pantoprazole, Dexamethasone and Ketorolac, among others.
02

Yes. Our manufacturing facility operates under WHO-GMP compliance and maintains classified cleanroom environments for sterile injectable production. Aseptic fill-finish processes are validated, and environmental monitoring is conducted as standard. The facility holds a valid manufacturing licence and WHO-GMP certificate — both available for review on request.
03

We manufacture across all three primary injectable formats — vial liquid (single and multi-dose), glass ampoules and dry powder injections for molecules requiring reconstitution at point of use. Container closure integrity testing is conducted on every batch as part of our standard release protocol.
04

Yes. 9M India is experienced in institutional and government injectable supply — including state tender programmes, CGHS and ESIC supply, and central procurement. Our injectable products are DCGI-approved and our documentation package — COA, COC, stability data, manufacturing licence and WHO-GMP certificate — is pre-prepared for tender bid submission with zero lead time.
05

Standard documentation issued with every batch includes Certificate of Analysis (COA) and Certificate of Conformance (COC) from our in-house QC laboratory. For export registration and regulatory filing, we additionally provide: stability study data (ICH-aligned conditions), process validation reports, product dossiers, DCGI manufacturing licence and WHO-GMP certificate. Documentation is available within 24 hours of request.